☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
2016
Regeneron and Intellia Expand Their 2016 Collaboration to Develop CRISPR/CAS9 Based Therapies
June 2, 2020
AstraZeneca Terminates Their License Agreement with Allergan for Brazikumab Signed in 2016
May 11, 2020
Evotec Expands its 2016 Agreement with Bristol-Myers Squibb
January 7, 2020
AbbVie Exercises its Option to License Agreement for BioArctic's Alpha-Synuclein Antibody Portfolio- Signed in 2016
November 2, 2018
Load more...
Back to Home
Modal title
×
Modal body text goes here.
